N-Alkyl Carbazole Derivatives as New Tools for Alzheimer’s Disease: Preliminary Studies-Reference-Cited by-同舟云学术

N-Alkyl Carbazole Derivatives as New Tools for Alzheimer’s Disease: Preliminary Studies

Published:2014-07-02 Issue:7 Volume:19 Page:9307-9317
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Saturnino Carmela,Iacopetta Domenico,Sinicropi Maria,Rosano Camillo,Caruso Anna,Caporale Angelamaria,Marra Nancy,Marengo Barbara,Pronzato Maria,Parisi Ortensia,Longo Pasquale,Ricciarelli Roberta

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/19/7/9307/pdf

Reference35 articles.

1. Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-roman period to the 1960s;Berchtold;Neurobiol. Aging,1998

2. Forecasting the global burden of Alzheimer’s disease;Brookmeyer;Alzheimers Dement.,2007

3. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide;Haass;Cell,1993

4. Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex

5. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of multitarget hybrid molecules containing NHC-Au(I) complexes and carbazole moieties;European Journal of Medicinal Chemistry;2024-11

2. The Potential of Indole Alkaloids in Bone Health and Osteoporosis Management;Applied Sciences;2024-09-10

3. New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands;European Journal of Medicinal Chemistry;2024-09

4. Heterocyclic Nitrogen Compounds as Potential PDE4B Inhibitors in Activated Macrophages;Applied Sciences;2024-08-02

5. CHARACTERIZATION OF NOVEL CARPROFEN DERIVATIVES AS INHIBITORS OF THE SEROTONIN 5-HT2C RECEPTORS AND CLK4-KD PROTEIN KINASE FOR THE DEVELOPMENT OF PHARMACOLOGICALLY ACTIVE COMPOUNDS;FARMACIA;2023-12-28